Skip to main content Help with accessibility Skip to main navigation

Mometasone furoate and olopatadine hydrochloride nasal spray (Ryaltris®) for treatment of moderate to severe nasal symptoms associated with allergic rhinitis

CCG Approval Status:

Date Added: 26 - Sep - 2024
Body System:
Green

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of mometasone furoate 25 micrograms and olopatadine hydrochloride equivalent to 600 micrograms nasal spray (Ryaltris®) for treatment of moderate to severe nasal symptoms associated with allergic rhinitis.

NHS Cheshire and Merseyside APPROVED